Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Vanguard World Funds Extended Duration ETF
EDV
$3.27B
| $1.32M | ﹤0.01% |
+7,900
| New | +$1.17M |
|
|
TMHC
2277
DELISTED
Taylor Morrison
TMHC
| $1.32M | ﹤0.01% |
120,453
-1,707,739
| -93% | -$36.7M |
|
|
NGHC
2278
DELISTED
National General Holdings Corp
NGHC
| $1.32M | ﹤0.01% |
79,800
-28,200
| -26% | -$565K |
|
2279
Visteon
VC
$2.78B
| $1.32M | ﹤0.01% |
+27,500
| New | +$2M |
|
2280
AerCap
AER
$23.8B
| $1.32M | ﹤0.01% |
57,800
-141,428
| -71% | -$6.98M |
|
|
HARP
2281
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.32M | ﹤0.01% |
11,360
+170
| +2% | +$23.9K |
|
2282
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
| $1.31M | ﹤0.01% |
36,500
+25,800
| +241% | +$1.23M |
|
|
NP
2283
DELISTED
Neenah, Inc. Common Stock
NP
| $1.31M | ﹤0.01% |
30,475
+375
| +1% | +$22.2K |
|
2284
Geospace Technologies
GEOS
$75.7M
| $1.31M | ﹤0.01% |
204,834
-10,300
| -5% | -$123K |
|
2285
Champions Oncology
CSBR
$72.1M
| $1.31M | ﹤0.01% |
177,046
-10,300
| -5% | -$72K |
|
2286
Eagle Bancorp Montana
EBMT
$190M
| $1.31M | ﹤0.01% |
80,769
-23,757
| -23% | -$461K |
|
2287
Helix Energy Solutions
HLX
$1.41B
| $1.31M | ﹤0.01% |
798,229
+124,800
| +19% | +$822K |
|
2288
Rocket Pharmaceuticals
RCKT
$394M
| $1.31M | ﹤0.01% |
+93,600
| New | +$1.85M |
|
|
PVBC
2289
DELISTED
Provident Bancorp
PVBC
| $1.3M | ﹤0.01% |
150,553
-33,524
| -18% | -$371K |
|
2290
Hartford Financial Services
HIG
$39.3B
| $1.3M | ﹤0.01% |
+36,800
| New | +$1.92M |
|
2291
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.5B
| $1.3M | ﹤0.01% |
36,300
+8,500
| +31% | +$348K |
|
2292
Cabot Corp
CBT
$4.52B
| $1.3M | ﹤0.01% |
49,600
-39,100
| -44% | -$1.49M |
|
2293
Coherus Oncology
CHRS
$196M
| $1.3M | ﹤0.01% |
79,900
-48,100
| -38% | -$889K |
|
2294
Chicago Rivet & Machine Co
CVR
$10.3M
| $1.3M | ﹤0.01% |
61,110
-1,300
| -2% | -$31.4K |
|
|
CLPR
2295
Clipper Realty
CLPR
$46.2M
| $1.29M | ﹤0.01% |
249,787
-8,870
| -3% | -$87.8K |
|
|
ESXB
2296
DELISTED
Community Bankers Trust Corporation
ESXB
| $1.29M | ﹤0.01% |
266,807
+50,800
| +24% | +$404K |
|
2297
Vanguard Energy ETF
VDE
$9.74B
| $1.29M | ﹤0.01% |
33,800
+30,200
| +839% | +$1.92M |
|
2298
First Community Corp
FCCO
$322M
| $1.29M | ﹤0.01% |
82,140
-5,649
| -6% | -$107K |
|
2299
Dynatrace
DT
$14.2B
| $1.29M | ﹤0.01% |
+54,125
| New | +$1.56M |
|
|
SBT
2300
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $1.29M | ﹤0.01% |
299,933
-26,900
| -8% | -$175K |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.